MCRB Historical Earnings image   This MCRB historical earnings page last updated 11/15/2024
MCRB Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202411/13/2024NA
Q2 20248/13/2024NA
Q1 20245/8/2024NA
Q4 20233/5/20240.06M
Q3 202311/2/20230.00B
Q2 20238/8/20230.13B
Q1 20235/9/2023-0.00B
Q4 20223/7/20230.00B
Q3 202211/2/20220.00B
Q2 20228/3/20220.00B
Q1 20225/4/20220.00B
Q4 20213/1/20220.01B
Q3 202111/10/20210.13B
Q2 20218/3/20210.01B
Q1 20215/4/20210.01B
Q4 20203/2/20210.02B
Q3 202011/9/20200.00B
Q2 20207/28/20200.01B
Q1 20205/7/20200.01B
Q4 20193/2/20200.01B
Q3 201911/5/20190.01B
Q2 20198/6/20190.01B
Q1 20195/2/20190.01B
Q4 20183/6/201910.63M
Q3 201811/8/20189.05M
Q2 20188/2/20184.61M
Q1 20185/9/20183.97M
Q4 20173/8/20183.06M
Q3 201711/8/201723.02M
Q2 20178/3/20173.01M
Q1 20175/4/20173.02M
Q4 20163/16/20173.04M
Q3 201611/10/201613.02M
Q2 20168/11/20163.00M
Q1 20165/16/20162.71M
MCRB Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202411/13/2024-0.330
Q2 20248/13/2024-0.220
Q1 20245/8/2024-0.270
Q4 20233/5/2024-0.320
Q3 202311/2/2023-0.370
Q2 20238/8/20230.360
Q1 20235/9/2023-0.570
Q4 20223/7/2023-0.540
Q3 202211/2/2022-0.490
Q2 20228/3/2022-0.700
Q1 20225/4/2022-0.610
Q4 20213/1/2022-0.550
Q3 202111/10/20210.720
Q2 20218/3/2021-0.530
Q1 20215/4/2021-0.390
Q4 20203/2/2021-0.190
Q3 202011/9/2020-0.360
Q2 20207/28/2020-0.280
Q1 20205/7/2020-0.280
Q4 20193/2/2020-0.250
Q3 201911/5/2019-0.230
Q2 20198/6/2019-0.240
Q1 20195/2/2019-0.590
Q4 20183/6/2019-0.52
Q3 201811/8/2018-0.54
Q2 20188/2/2018-0.68
Q1 20185/9/2018-0.69
Q4 20173/8/2018-0.72
Q3 201711/8/2017-0.17
Q2 20178/3/2017-0.69
Q1 20175/4/2017-0.63
Q4 20163/16/2017-0.63
Q3 201611/10/2016-0.46
Q2 20168/11/2016-0.7
Q1 20165/16/2016-0.5
Quotes delayed 20 minutes

Email EnvelopeFree MCRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Seres Therapeutics (MCRB) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MD Historical Earnings
MDGL Historical Earnings
MDT Historical Earnings
MDXG Historical Earnings
ME Historical Earnings
MEDP Historical Earnings
MEIP Historical Earnings
MGLN Historical Earnings
MGNX Historical Earnings
MGRM Historical Earnings
What was the record high MCRB historical earnings result?
In terms of earnings or revenue, what is the best MCRB historical earnings result that Seres Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest MCRB historical earnings result was set in Q3 2021, when Seres Therapeutics posted results of 0.720/share. The most successful revenue quarter within our data set was Q3 2021 when Seres Therapeutics reported revenue of 0.13B.

What was the lowest Seres Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest MCRB has reported, and when?

✔️Accepted answer: Within our data set, the lowest MCRB historical earnings result was set in Q4 2017, when Seres Therapeutics posted results of -0.72/share. The smallest revenue quarter within our data set was Q1 2023 when Seres Therapeutics reported revenue of -0.00B.

On this page we presented the MCRB historical earnings date information for Seres Therapeutics. Reviewing that MCRB Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2021, when MCRB posted gaap of 0.720/share. Meanwhile the lowest MCRB historical earnings result was in Q4 2017, when MCRB posted gaap of -0.72/share. Moving to Seres Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2021 when MCRB reported 0.13B in revenue, while the smallest revenue quarter was Q1 2023 when MCRB reported -0.00B in revenue.

For self directed investors doing their due diligence on MCRB or any other given stock, their research can benefit from looking into all of the Seres Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Seres Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for MCRB. Thanks for visiting, and the next time you need to research MCRB historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding ECHO, LAD Next Dividend Date, Top 10 Hedge Funds Holding International Flavors and Fragrances.

 

MCRB Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.